Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by biodelatechon Nov 13, 2007 7:51am
173 Views
Post# 13797178

RE: RE: RE: My response fron IR

RE: RE: RE: My response fron IREither Roche opts in on the stipulated terms or they are out. the downside from here is getting smaller every day. at 80 cents a Roche opting out is kinda priced in. I have said it over and over again . If 247 matches 247 in terms of efficacy and has a better side-effects profile than tacro than we have the upper hand. roche may try to play hardball but we should stay firm. meaning:not giving them psoriasis and not renegotiate the current terms for transplantation. If roche wants 247 they will give in as they did in the IGEN standoff. Roche needed IGEN´s technology and in the end had to pay hundreds of millions. what I want to say is that if Roche wants 247, they will only play with us as long as they don´t risk to lose 247 altogether. If they don´t want 247 then we should knock on astellas´door. or maybe astellas comes knocking.
Bullboard Posts